Reduced lymphocyte-mediated antifungal capacity in high-risk infants

Linda Witek-Janusek1, Maliha J Shareef, Herbert L Mathews

  • 1Department of Maternal-Child Health, Loyola University of Chicago, Maywood, Illinois 60153, USA.

Insights

Premature infants exhibit reduced lymphocyte antifungal capacity against Candida albicans, impacting their susceptibility. Gestational age is the primary predictor of this impaired immune response in neonates.

Area of Science:

  • Immunology
  • Neonatology
  • Mycology

Background:

  • Premature and critically ill infants face heightened susceptibility to Candida albicans infections.
  • Candida albicans poses a significant threat to vulnerable neonatal populations.

Purpose of the Study:

  • To evaluate the lymphocyte-mediated antifungal capacity in infants.
  • To determine the relationship between infant factors (birth weight, prematurity, illness severity) and antifungal immune function.

Main Methods:

  • Assessed lymphocyte-mediated growth inhibition of Candida albicans.
  • Measured lymphocyte adhesion to Candida albicans.
  • Correlated immune function with birth weight, gestational age, and Score for Neonatal Acute Physiology (SNAP).

Main Results:

  • Lymphocytes from preterm and low-birth weight infants showed significantly reduced inhibition and adhesion to Candida albicans.
  • Infants with higher illness severity (SNAP score ≥10) had diminished antifungal capacity and fungal adhesion.
  • Gestational age was the strongest predictor of both lymphocyte-mediated growth inhibition and fungal adhesion.

Conclusions:

  • Infant gestational age is a critical determinant of lymphocyte-mediated antifungal immunity.
  • Reduced lymphocyte antifungal capacity and adhesion in preterm and ill infants may contribute to increased Candida albicans susceptibility.
  • Immune function in neonates is significantly influenced by prematurity and illness severity.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...